In Vitro and In Vivo Anti Hyperglycemic Evaluation of Sterculia quadrifida Bark through The Inhibition of Alpha Glucosidase

Jeffry Julianus(1), Maria Dewi Puspitasari Tirtaningtyas Gunawan-Puteri(2), Radhita Tyastu Puteri Wiwengku(3), Agustina Setiawati(4), Phebe Hendra(5*),

(1) Faculty of Pharmacy, Sanata Dharma University, Yogyakarta 55282, Indonesia
(2) Department of Food Technology, Swiss German University, Tangerang, Indonesia
(3) Faculty of Pharmacy, Sanata Dharma University, Yogyakarta 55282, Indonesia
(4) Faculty of Pharmacy, Sanata Dharma University, Yogyakarta 55282, Indonesia
(5) Faculty of Pharmacy, Sanata Dharma University, Yogyakarta 55282, Indonesia
(*) Corresponding Author

Abstract


Data from the International Diabetes Federation revealed annual increases in the prevalence of diabetes mellitus, which require special attention. Implementation of the ‘back to nature’ trend presents opportunities to overcome this problem. As a medicinal plant, Faloak is widely used by people in Nusa Tenggara Timur, Indonesia. This study aimed to evaluate in vivo and in vitro anti-hyperglycemic activity of the bark of Sterculia quadrifida, known as Faloak. In vivo evaluation used sucrose-induced male mice. Measurements of glucose level employed a glucometer and data were analyzed statistically. Demonstrating anti-hyperglycemic activity of the bark of Faloak decoct, results showed doses 1.67 and 3.3 g/kg BW reduced glucose levels by 62.2% and 56.9%, respectively. In vitro examination of Faloak decoct at various concentrations used alpha glucosidase (sucrose) enzymatic reaction. Results of in vitro examinations demonstrated of Faloak bark decoct inhibited alpha glucosidase (sucrose) activity by 42.09 ± 4.39%. Further testing on humans is needed to confirm these findings.

Keywords


Anti-hyperglycemic; alpha glucosidase inhibitor; Faloak; in vivo; in vitro

Full Text:

PDF

References


Abe, M., Kazuyoshi, O., Masayoshi, S., 2011. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice. Curr. Drug Metab., 12(1): 57-69.

Alssema, M., Carolien, R., Ellen, E.B., Léonie, E., Pierre, D, Sophie, V., Jacqueline, M.D., Robertson, M.D., 2021. Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis. Nutr. Diabetes, 11(1): 1-9.

Bhatia, A., Singh, B., Arora, R., Arora, S., 2019. In vitro evaluation of the α-glucosidase inhibitory potential of methanolic extracts of traditionally used antidiabetic plants. BMC Complement. Altern. Med., 19(1): 1-9.

Borgesa, P.H.O., Pedreiro, S., Baptista, S.J., Geraldes, C.F.G.C., Batista, M.T., Silva, M.C.M., Figueirinha, A., 2021. Inhibition of α-glucosidase by flavonoids of Cymbopogon citratus (DC) Stapf. Journal of Ethnopharmacology, 280 (15): 11470.

Cai, X., Xueyao, H., Yingying, L., Linong, J., 2013. Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian. PLoS ONE, 8(11): 1-10.

Dej-adisai, S., Pitakbut, T., Wattanapiromsakul, C., 2017. Alpha-glucosidase inhibitory activity and phytochemical investigation of Borassus flabellifer Linn. Afr. J. Pharmc. Pharmacol., 11(3): 45-52.

de Oliveira, A.P., Coppede, J.S., Bertoni, B.W., Crotti, A.E.M., França, S.C., Pereira, A.M.S., Taleb-Contini, S.H., 2018. Costus spiralis (Jacq.) Roscoe: A Novel Source of Flavones with α-Glycosidase Inhibitory Activity. Chem. Biodivers., 15: 1-6.

Dongga, I.R.Y., Sunarti, S.T., 2016. Aktivitas Antidiabetes Ekstrak Etanol Kulit Batang Faloak (Sterculia quadrifida R.Br.) Terhadap Tikus Wistar yang Diinduksi Aloksan. JFI, (2): 144-149.

Elya, B., Katrin, B., Abdul, M., Wulan, Y., Anastasia, B., Eva, K.S., 2012. Screening of α-glucosidase inhibitory activity from some plants of Apocynaceae, Clusiaceae, Euphorbiaceae, and Rubiaceae. J. Biomed. Biotechnol., 2012: 1-6.

Fernandez, S., Edel, E., 2017. Pengaruh Pemberian Ekstrak Etanol Kulit Batang Faloak (Sterculia Sp.) Terhadap Penurunan Kadar Glukoasa Darah Yang Diinduksi Glukosa. J. Info. Kesehat., 15(1): 460-464.

Fransisca, K.G.E., Saptasari, D.C., Hendra, P., 2018. The effect of Pasak Bumi roots towards blood glucose level in glucose-loaded mice. J. Pharm. Sci. Community, 15(1): 1-6.

Gunawan-Puteri, M.D.P.T., Kawabata, J., 2010. Novel α-glucosidase inhibitors from Macaranga tanarius leaves. Food Chem., 123(2): 384-389.

Gunawan-Puteri, M.D.P.T., Rustandi, F., Hendra, P., 2018. Spray dried aqueous extract of Lemongrass (Cymbopogon citratus) exhibits in vitro and in vivo anti hyperglycemic activities. J. Pharm. Sci. Community, 15 (2): 55-61.

Gunawan-Puteri, M.D.P.T., Tjiptadi, F.M., Hendra, P., Santoso, F., Udin, Z., Artanti, N., Ignatia, F., 2020. Lemongrass (Cymbopogon citratus) ethanolic extract exhibited activities that inhibit α-glucosidase enzymes and postprandial blood glucose elevation. Makara J. Sci., 24 (4): 219-227.

Hendra, P., Rizki, N., Safitri, E.N., 2021. Antihyperglycemic activities of Uli banana leaves on oral sugar tolerance. J. Funct. Food Nutr., 2(2): 75-79.

International Diabetes Federation. 2019. IDF Diabetes Atlas, 9th ed. International Diabetes Federation, Brussels.

Joshi, S.R., Eberhard, S., Nanwei, T., Parag, S., Sanjay, K., Rahul, R., 2015. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert Opin. Pharmacother., 16(13): 1959-1981.

Kato, J., Yohei, S., Taku, M., Masaya, K., Hiroyasu, S., Takashi, I., Masahito, S., 2020. Alpha-glucosidase inhibitor Voglibose suppresses azoxymethane-induced colonic preneoplastic lesions in diabetic and obese mice. Int. J. Mol. Sci., 21(6): 1-16.

Kottaisamy, C.P.D., Raj, D.S., Kumar, V.P., Sankaran, U., 2021. Experimental animal models for diabetes and its related complications: a review. Lab. Anim. Res., 37(1): 1-14.

Kim, M.K., Ko, S-H., Kim, B-Y., Kang, E.S., Noh, J., Kim, S.K., Park, S-O., et al., 2019. Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea. Diabetes Metab. J., 43: 398-406.

Laube, H., 2022. Acarbose: an update of its therapeutic use in diabetes treatment. Clin. Drug Invest., 22 (3): 141-156.

Laoufi, H., Benariba, N., Adjdir, S., Djaziri, R., 2017. In vitro α-amylase and α-glucosidase inhibitory activity of Ononis angustissima extracts. J. App. Pharm. Sci., 7 (02): 191-198.

Luyen, N.T., Dang, N.H., Binh, P.T.X., Hai, N.T., Dat, N.T., 2018. Hypoglycemic property of triterpenoid saponin pfs isolated from Polyscias fruticosa leaves. An Acad. Bras. Cienc., 90(3): 2881-2186.

Marín-Peñalver, J.J., Martín-Timón, I., Sevillano-Collantes, C., del Cañizo-Gómez, F.J., 2016. Update on the treatment of type 2 diabetes mellitus. World J. Diabetes, 7(17): 354-395.

Matsumoto, Y., Ishii, M., Sekimizu, K., 2016. An in vivo invertebrate evaluation system for identifying substances that suppress sucrose-induced postprandial hyperglycemia. Sci Rep., 6: 26354.

Mosenzon, O., Pollack, R., Raz, I., 2016. Treatment of type 2 diabetes: from guidelines to position statements and back recommendations of the Israel National Diabetes Council. Diabetes Care, 39(August): S146-53.

Munawaroh, R., Siswadi, Setyowati, E.P., Murwanti, R., Hertiani, T., 2018. Korelasi Antara Kadar Flavonoid Total dan Aktivitas Fagositosis Makrofag Fraksi-Fraksi dari Ekstrak Etanol Kulit Batang Faloak (Sterculia quadrifida R.Br.) Secara In Vitro. Traditional Medicine Journal, 23(1): 47-55.

Poovitha, S., Parani, M., 2016. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement. Altern. Med. 16(Suppl 1): 185.

Proença, C., Freitas, M., Ribeiro, D., Oliveira, E.F.T., Sousa, J.L.C., Tomé, S.M., Ramos, M.J., et al. 2017. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study. J. Enzyme Inhib. Med. Chem., 32(1): 1216-1228.

Qaisar, M.N., Chaudhary, B.A., Sajid, M.U., Hussain, N., 2014. Evaluation of α-glucosidase inhibitory activity of dichloromethane and methanol extracts of Croton bonplandianum Baill. Trop. J. Pharm. Res., 13(11): 1833-1836.

Shi, Z.L., Liu, Y.D., Yuan, Y.Y., Song, D., Qi, M.F., Yang, X.J., Wang, P., Li, X.Y., et al., 2017. In vitro and in vivo effects of norathyriol and mangiferin on α-glucosidase. Biochem. Res. Int., 2017: 1-7.

Siswadi, S., Saragi, G.S., 2021. Phytochemical analysis of bioactive compounds in ethanolic extract of Sterculia quadrifidaR.Br. International Conference on Life Sciences and Technology, in: AIP Conference Proceedings 2353, pp. 030098-1-030098-7.

Skyler, J.S., Bakris, G.L., Bonifacio, E., Darsow, T., Eckel, R.H., Groop, L., Groop, P.H., Handelsman, Y., Insel, R.A., et al., 2017. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes, 66(2): 241-255.

Sugimoto, S., Nakajima, H., Kosaka, K., Hosoi, H., 2015. Review: Miglitol has potential as a therapeutic drug against obesity. Nutr. Metab., 12(1): 1-7.

Thrasher, J., 2017. Pharmacologic management of type 2 diabetes mellitus: available therapies. Am J Med, 130(6): S4–17.

Togashi, Y., Shirakawa, J., Okuyama, T., Yamazaki, S., Kyohara, M., Miyazawa, A., Suzuki, T., et al., 2016. Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice. Sci. Rep. 2016; 6: 25465.

Wahyuningsih, D., Purnomo, Y., 2018. Antidiabetic effect of Urena lobata: preliminary study on hexane, ethanolic, and aqueous leaf extracts. Jurnal Kedokteran Brawijaya. 30(1): 1-6.

World Health Organization. 2019. Classification of Diabetes Mellitus. WHO, Geneva.

Wulandari., 2016. Uji Efektivitas Antihiperglikemia Kombinasi Jus Pare (Momordica charantia L) dan Jus Tomat (Solanum lycopersicum L) pada Tikus Wistar Jantan dengan Metode Toleransi Glukosa. J. Pharm. Sci. Res., 3(3): 145-154.

Zhou, J.Y., Zhou, S.W., Zeng, S.Y., Zhou, J.Y., Jiang, M.J., He, Y., 2012. Hypoglycemic and hypolipidemic Effects of ethanolic extract of Mirabilis jalapa L. root on normal and diabetic mice. Evid. Based Complement. Alternat. Med., 2012: 1-9.

Zhou, D., Chen, L., Mou,, X. 2021. Acarbose ameliorates spontaneous type‑2 diabetes in db/db mice by inhibiting PDX‑1 methylation. Molecular Medicine Reports, 23 (72).




DOI: https://doi.org/10.24071/jpsc.005153

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community)

 

 

 

 

 

 

 

  

Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community)

Published by Faculty of Pharmacy, Universitas Sanata Dharma Yogyakarta

Creative Commons Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.